Express Scripts HealthBridge Pharma & Biotech to Provide Specialty Pharmacy and Specialty Distribution Services for EYLEA™ (aflibercept) Injection
ST. LOUIS, Jan. 4, 2012 /PRNewswire/ -- Express Scripts now provides services for EYLEA, a product of Regeneron, through its HealthBridge Pharma & Biotech services. CuraScript, a wholly owned subsidiary of Express Scripts and part of the HealthBridge suite of services, will be among a limited number of specialty pharmacies and specialty distributors for EYLEA.
EYLEA (aflibercept) Injection was approved by the Food and Drug Administration on Nov. 18 and is indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD). Macular degeneration is diagnosed as either dry (non-vascular) or wet (vascular) and is a leading cause of blindness in older adults. The wet form usually leads to more serious vision loss.
"With a growing aging population, more and more people are affected by macular degeneration," explains Rob Osborne, Express Scripts senior director, business development, Pharma & Biotech. "HealthBridge Pharma & Biotech is proud to provide services that will help patients get the medication they need to treat this debilitating disease."
About HealthBridge Pharma & Biotech
HealthBridge Pharma & Biotech provides a suite of services offering pharmaceutical and biotech companies a single solution approach to patient care. These services include: CuraScript SP Specialty Pharmacy, CuraScript SD Specialty Distribution, Freedom Fertility Pharmacy, risk evaluation and mitigation strategies (REMS), reimbursement, patient assistance programs, data and sales reporting, enhanced account services, and customized adherence programs. More information can be found at http://www.TheHealthBridgeSolution.com/.
As a service of HealthBridge Pharma & Biotech, CuraScript Specialty Pharmacy is a wholly owned subsidiary of Express Scripts. CuraScript manages the largest number of exclusive Pharma & Biotech programs in the industry and has been involved in nearly every specialty product launch over the last eight years. CuraScript services more than 1,800 plan sponsors that cover tens of millions of Americans.
CuraScript Specialty Distribution, an Express Scripts subsidiary, is a premier provider of comprehensive distribution solutions for physicians' offices, practices, surgery centers, hospitals and other clinical settings.
About Express Scripts
Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, is leading the way toward creating better health and value for patients through Consumerology®, the advanced application of the behavioral sciences to healthcare. This approach is helping millions of members realize greater healthcare outcomes and lowering cost by assisting in influencing their behavior. Headquartered in St. Louis, Express Scripts provides integrated PBM services including network-pharmacy claims processing, home delivery services, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services. More information can be found at http://www.express-scripts.com/ and http://www.consumerology.com/.
Media Contact: Thom Gross
314.684.6321
[email protected]
SOURCE Express Scripts
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article